Compare HGLB & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HGLB | CBUS |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.7M | 69.9M |
| IPO Year | N/A | 2017 |
| Metric | HGLB | CBUS |
|---|---|---|
| Price | $9.01 | $1.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 91.8K | ★ 172.0K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 13.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.42 | $1.09 |
| 52 Week High | $9.45 | $3.88 |
| Indicator | HGLB | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 35.22 | 55.00 |
| Support Level | $8.96 | $1.49 |
| Resistance Level | $9.74 | $1.62 |
| Average True Range (ATR) | 0.29 | 0.14 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 11.99 | 58.70 |
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.